NASDAQ: PODD - Insulet Corporation

Yield per half year: +33.31%
Dividend yield: 0.00%
Sector: Healthcare

Company Analysis Insulet Corporation

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (65.23%) is higher than the sector average (-21.54%).
  • Current debt level 2.71% is below 100% and has decreased over 5 years from 77.69%.
  • The company's current efficiency (ROE=43.03%) is higher than the sector average (ROE=9.78%)

Disadvantages

  • Price (270.31 $) is higher than fair price (146.54 $)
  • Dividends (0%) are below the sector average (0.5351%).

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Insulet Corporation Healthcare Index
7 days -4.7% -20.4% -3.1%
90 days 1.3% -22.2% -6.9%
1 year 65.2% -21.5% 13.5%

PODD vs Sector: Insulet Corporation has outperformed the "Healthcare" sector by 86.76% over the past year.

PODD vs Market: Insulet Corporation has outperformed the market by 51.73% over the past year.

Stable price: PODD is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: PODD with weekly volatility of 1.25% over the past year.

3. Summary of the report

3.1. General

P/E: 46.52
P/S: 9.39

3.2. Revenue

EPS 5.66
ROE 43.03%
ROA 14.74%
ROIC 5.25%
Ebitda margin 14.91%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (270.31 $) is higher than the fair price (146.54 $).

Price is higher than fair: The current price (270.31 $) is 45.8% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (46.52) is lower than that of the sector as a whole (57.27).

P/E vs Market: The company's P/E (46.52) is lower than that of the market as a whole (49.14).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (16.06) is higher than that of the sector as a whole (4.64).

P/BV vs Market: The company's P/BV (16.06) is higher than that of the market as a whole (3.44).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (9.39) is lower than that of the sector as a whole (33.44).

P/S vs Market: The company's P/S indicator (9.39) is lower than that of the market as a whole (10.29).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (60.18) is higher than that of the sector as a whole (-17.68).

EV/Ebitda vs Market: The company's EV/Ebitda (60.18) is higher than that of the market as a whole (25.46).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 1374.33% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (1374.33%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (106.41%).

5.4. ROE

ROE vs Sector: The company's ROE (43.03%) is higher than that of the sector as a whole (9.78%).

ROE vs Market: The company's ROE (43.03%) is higher than that of the market as a whole (8.96%).

5.5. ROA

ROA vs Sector: The company's ROA (14.74%) is higher than that of the sector as a whole (0.33%).

ROA vs Market: The company's ROA (14.74%) is higher than that of the market as a whole (6.33%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (5.25%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (5.25%) is lower than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (2.71%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 77.69% to 2.71%.

Debt Covering: The debt is covered by 20.03% from net profit.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.5351%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (5.14%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
12.11.2024 BORIO LUCIANA
Director
Sale 274.8 139 598 508
09.09.2024 Budden Lauren
Group VP, CAO and Controller
Sale 221.41 333 443 1 506
09.09.2024 Field Mark N
SVP & Chief Technology Officer
Sale 220.87 305 463 1 383
28.08.2024 Field Mark N
SVP & Chief Technology Officer
Sale 203 281 561 1 387
28.08.2024 Field Mark N
Officer
Purchase 203 281 561 1 387

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Insulet Corporation

9.3. Comments